COCO vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

COCO

37.6
AI Score
VS
UTI Wins

UTI

66.6
AI Score

Investment Advisor Scores

COCO

38score
Recommendation
SELL

UTI

67score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric COCO UTI Winner
Revenue 292.93M 661.15M UTI
Net Income 22.43M 15.54M COCO
Net Margin 7.7% 2.4% COCO
Operating Income 29.66M 19.27M COCO
ROE 23.8% 4.5% COCO
ROA 11.2% 1.7% COCO
Total Assets 200.97M 897.86M UTI
Cash 35.91M 130.06M UTI
Current Ratio 2.45 1.30 COCO
Free Cash Flow -16.48M -63.50M COCO

Relative Price Performance (Last 90 Days)

COCO 1M: -21.7% · 3M: -33.9% UTI 1M: -20.8% · 3M: -50.2%

Current Technical Phase

COCO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.0%), weak momentum, RSI 26

RSI (14): 25.9 · Price: $52.01

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.7%), weak momentum, RSI 27

RSI (14): 26.9 · Price: $20.31

Fundamentals Snapshot

Metric COCO UTI
Market Cap
Forward P/E 22.2 27.6
Trailing P/E 28.4 34.9
Revenue (TTM)
Revenue Growth 0.3% 0.1%
Gross Margin 0.4% 0.6%
Operating Margin 0.3% 0.0%
EPS 1.80 0.59
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.